Fair question to ask before paying for anything: is the work any good?
So rather than describe it, here is one. The Johnson & Johnson deep dive is unlocked. No signup, no card, nothing behind it.
This is the kind of thing that only comes up when you read.
A screener will tell us Johnson & Johnson pays out 47% of earnings and move on. Open the cash flow statement, and the dividend takes 63% of free cash flow ($12.4B of dividends / $19.7B of free cash flow). Add the $6 billion buyback sitting ahead of it in the capital priority order, and 93% of every free cash flow dollar is already spoken for.
Same company, same year. One number says plenty of room. The other says almost none.
That is not a reason to avoid JNJ, and the deep dive says so. It is the difference between a screen and an analysis.
What a screen gives us: a list.
What it does not give us: how the money gets made, what would have to break for that to stop, or whether the dividend survives a bad year. Reading gets us those, and reading takes time most of us do not have on a Saturday.
That one is out of the infographic library. There are 250 more, and they come with the membership.
One company gets the JNJ treatment every month. Twelve sections, start to finish, every number out of the filings.
So what is not unlocked? August’s deep dive, the three unnamed September Best Buys, and every Buy Below price on the board.
Through Sunday, it is $299 for the year instead of $369, locked at $299 for as long as the membership runs. Seven days free, then thirty days to change your mind.
Until next time, take care and be safe out there,
Dave
A screener tells you where to look. The financial statements tell you what you actually own. That distinction is easy to underestimate.